Russia's Ministry of Health registers Iqirvo and Hympavzi for the treatment of rare diseases
The Ministry of Health has registered two original drugs: elafibranor (Iqirvo) for adults with primary biliary cholangitis and marstacimab (Hympavzi) for the prevention of bleeding in severe hemophilia A and B in patients aged 12 and older. Both contain active ingredients registered for the first time.
Aziz Karimov